about
Insulin-like growth factor 1VimentinInterleukin 6Mechanistic target of rapamycin kinaseAtaxin 1Translocator proteinInterleukin 1 betaLYN proto-oncogene, Src family tyrosine kinaseE2F transcription factor 1Protein kinase C iotaProtein phosphatase 1 catalytic subunit gammaMYB proto-oncogene, transcription factorProtein kinase C etaETS variant transcription factor 5PLAG1 zinc fingerUFM1 specific ligase 1Lymphotoxin alphaTranslocator proteinMyelocytomatosis oncogeneProtein kinase C, etaProtein kinase C, iotaEts variant 5PTK2 protein tyrosine kinase 2Pleiomorphic adenoma gene 1Protein phosphatase 1 catalytic subunit gammaUFM1 specific ligase 1Tumor necrosis factorLymphotoxin AGlial fibrillary acidic proteinTranslocator proteinLYN proto-oncogene, Src family tyrosine kinaseProtein kinase C, etaLYN proto-oncogene, Src family tyrosine kinaseProtein phosphatase 1 catalytic subunit gammaTranslocator proteinProtein kinase C, iotaLymphotoxin alphaPLAG1 zinc fingerGlial fibrillary acidic proteinInsulin-like growth factor 1
P682
Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cellsPKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathwayEffects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro.Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor
P921
Q14863723-DB9DFEA8-A905-406A-B87A-1DB2D7DE3103Q14864871-028DC7BF-7D37-4257-B260-C73CE029FE76Q14865240-AA3EE86B-D729-4479-A44B-FDFCD8C03483Q14876092-0E593E1D-196F-4CA8-85F2-0474E31F26A6Q14905517-CDE98D6E-4FB7-48C1-AC93-69A81780DC11Q14913479-7E1E2EEB-7C18-4114-8747-F67B93ACA872Q14913479-F552C45F-1535-420B-89C5-E499349A23A1Q14916414-2E0438D5-1DAE-42A2-9AD6-68E818072FF1Q15331919-698C1B2D-4B7F-4E12-83DA-FAAEF3C6E30EQ15333021-E02E27F5-11F9-445E-A4D5-C84A89FD7898Q21109253-6794859C-61EC-4CA9-AB55-97EDD05443CCQ21109478-ECA2F694-033D-42BC-806D-7E5AF73483B3Q21109790-C67D8733-8166-46EC-8783-A364B99F2FA5Q21114857-8AF40D29-3D97-4F18-8B0A-C43AC32EDF31Q21115863-52EACAEE-5396-43E5-96DC-4EFE5E05D971Q21119733-FCCFDE37-6804-448A-9C0E-636369C316CEQ21123542-E1BF30DD-8792-4986-9CD5-323D23198102Q21124634-D199DF17-B469-4838-97C7-5C143E6B6911Q21135117-ADABA371-912D-4EB6-9491-DC343A4BDBBCQ21980001-E3758D98-FFB1-4E3A-8DF6-0F1012B7A482Q21984342-EADD03AE-E8F1-4FCB-A750-62FB321D123CQ21984342-FCDA6CFB-8350-4CCC-A0A6-A827D9DE48BBQ21984346-66692CBB-B6DD-45EA-B49C-A2D5EEE7D515Q21984469-96483896-E9F7-492E-9976-55F485AE9EC8Q21984735-CFB413A2-61F9-448D-970E-9AB852961CCFQ21989380-D535A823-183F-4D8B-A61E-4F7FC26BD201Q21989929-B75F4F4B-DA98-47D1-9746-52738C29986BQ21989929-EBD1A3C1-8B2E-483C-A41F-F65675F38297Q21991370-92B65CC2-ADC2-4608-877B-09A3E733CC45Q21992447-09C7F771-F568-46F3-A743-2F3245945347Q21992448-4B304ED1-4CC6-434B-8A98-1FFF896C8DC3Q22679578-C1F4F132-A66B-4F53-A946-E0BD278F661EQ2385013-61648EBF-13A8-42E7-84F1-CDF42905496BQ2463389-C563D9E8-5DF0-4F17-8516-97F63D25BF07Q28556111-811F72EA-1932-4C9C-8088-0682F4DA0034Q28556795-DAAB8938-BF53-4A8D-86D9-FC0665F35A03Q28557948-5AA018E2-70B0-4F56-9504-992940CAA584Q28558111-E2F36FEF-579B-4E62-BE5D-583F6BFD8546Q28558168-B3C37F91-6DD6-483A-A255-11898FF43D81Q28559024-1BEF8D4D-0135-43B4-9D03-C1EE2D4A7CC4
P682
description
Any process that activates or increases the rate or extent of glial cell proliferation.
@en
biologisch proces
@nl
name
positive regulation of glial cell proliferation
@en
type
label
positive regulation of glial cell proliferation
@en
altLabel
GO:0060252
@en
prefLabel
positive regulation of glial cell proliferation
@en
P279
P279
P2888
P686
GO:0060252